Bright Minds Biosciences Stock Performance
| DRUG Stock | USD 26.14 0.02 0.08% |
The firm shows a Beta (market volatility) of 1.28, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bright Minds will likely underperform. At this point, Bright Minds Biosciences has a negative expected return of -0.37%. Please make sure to confirm Bright Minds' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Bright Minds Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bright Minds Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return (0.08) | Five Day Return 6.22 | Year To Date Return (36.41) | Ten Year Return (3.19) | All Time Return (3.19) |
Last Split Factor 1:5 | Last Split Date 2023-07-14 |
1 | Bright Minds Biosciences Receives Buy Rating from Chardan Capital DRUG Stock News | 05/07/2025 |
2 | MADD Canada ritre sa demande de sanctions administratives pour les taux dalcoolmie de 0,05 percent 0,08 percent au Qubec | 05/23/2025 |
3 | Media Advisory MADD Canadas Team Nick Coates Awards Recognize Newfoundland and Labrador Police Officers for Keeping Roads Safe | 06/10/2025 |
4 | Les prix de lquipe Nick Coates de MADD Canada seront dcerns aux policiers de Terre-Neuve-et-Labrador pour leurs efforts exceptionnels en vue de la scurit routir... | 06/13/2025 |
5 | Prothena to lay off majority of staff Zealand shares obesity drug data | 06/20/2025 |
6 | Celebrate the Red and White Responsibly this Canada Day Drive Sober | 06/26/2025 |
7 | Business as usual at the grimy, drug-infested Broadway of the Bronx Worst Ive ever seen it | 07/09/2025 |
8 | Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report | 07/11/2025 |
9 | Acquisition by Cormorant Asset Management, Lp of 8900 shares of Bright Minds at 7.3052 subject to Rule 16b-3 | 07/18/2025 |
| Begin Period Cash Flow | 6.7 M |
Bright Minds Relative Risk vs. Return Landscape
If you would invest 3,410 in Bright Minds Biosciences on April 23, 2025 and sell it today you would lose (796.00) from holding Bright Minds Biosciences or give up 23.34% of portfolio value over 90 days. Bright Minds Biosciences is currently does not generate positive expected returns and assumes 3.7546% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Bright, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bright Minds Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bright Minds Biosciences, and traders can use it to determine the average amount a Bright Minds' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0976
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DRUG |
Estimated Market Risk
| 3.75 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bright Minds is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bright Minds by adding Bright Minds to a well-diversified portfolio.
Bright Minds Fundamentals Growth
Bright Stock prices reflect investors' perceptions of the future prospects and financial health of Bright Minds, and Bright Minds fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bright Stock performance.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.11 | ||||
| Current Valuation | 137.48 M | ||||
| Shares Outstanding | 7.08 M | ||||
| Price To Book | 4.55 X | ||||
| EBITDA | (7.28 M) | ||||
| Net Income | (2.8 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 118.96 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 7.87 X | ||||
| Cash Flow From Operations | (1.85 M) | ||||
| Earnings Per Share | (0.40) X | ||||
| Market Capitalization | 188.47 M | ||||
| Total Asset | 6.1 M | ||||
| Retained Earnings | (34.35 M) | ||||
| Working Capital | 5.46 M | ||||
About Bright Minds Performance
By analyzing Bright Minds' fundamental ratios, stakeholders can gain valuable insights into Bright Minds' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bright Minds has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bright Minds has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.53) | (0.55) | |
| Return On Capital Employed | (0.58) | (0.61) | |
| Return On Assets | (0.53) | (0.55) | |
| Return On Equity | (0.58) | (0.61) |
Things to note about Bright Minds Biosciences performance evaluation
Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bright Minds generated a negative expected return over the last 90 days | |
| Bright Minds has high historical volatility and very poor performance | |
| Bright Minds has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Roughly 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report |
- Analyzing Bright Minds' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bright Minds' stock is overvalued or undervalued compared to its peers.
- Examining Bright Minds' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bright Minds' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bright Minds' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bright Minds' stock. These opinions can provide insight into Bright Minds' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |